The CXCL12/CXCR4/STAT3 pathway can promote the expression of IL-10 in chronic lymphocytic leukemia (CLL) cells, inducing immunosuppression. This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.